With all due respect ringwraith HTW is completely different from SBN.
I held HTW for about 2 years (lost about 12%) so I know the company very well, and their business model is
completely dissimilar.
The LVAD is a potential market leader, and if HTW ever get their MVAD through clinical trials and implanted in patients then they will be the next Cochlear, with a device that will transform the way people live, and a patent that will transform the lives of investors. But that is many years away.
SBN are selling saliva tests in boxes of 10 for a few dollars, and need to build market awareness and get their sales & distribution network pumping to develop massive volume.
Personally I think that SBN's greatest future lies in their IP. Now that it's been successully defended and subsequently licensed SBN is in a much stronger position than they were when they released the last quarterly.
Looking at a re-entry, and have changed my sentiment to match.
All IMO only of course.
- Forums
- ASX - By Stock
- SBN
- a comparison for the despairing
a comparison for the despairing, page-3
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries